Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

AUROBINDO PHARMA LTD

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 24
  • 0 comments

FDA approve IBUPROFEN

Comment Full text

UNICHEM

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 31
  • 0 comments

FDA approve ETODOLAC

Comment Full text

AUROBINDO PHARMA

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 30
  • 0 comments

FDA approve OMEPRAZOLE; SODIUM BICARBONATE

Comment Full text

NEXUS

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 35
  • 0 comments

FDA approve METHYLENE BLUE

Comment Full text

SCIEGEN PHARMS INC

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 36
  • 0 comments

FDA approve ESOMEPRAZOLE MAGNESIUM; NAPROXEN

Comment Full text

LEADING

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 37
  • 0 comments

FDA approve KETOROLAC TROMETHAMINE

Comment Full text

SLATE RUN PHARMA

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 34
  • 0 comments

FDA approve CINACALCET HYDROCHLORIDE

Comment Full text

AMNEAL

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 29
  • 0 comments

FDA approve DICLOFENAC SODIUM

Comment Full text

GLENMARK PHARMS LTD

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 30
  • 0 comments

FDA approve INDOMETHACIN

Comment Full text

DR REDDYS

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 33
  • 0 comments

FDA approve ESOMEPRAZOLE MAGNESIUM; NAPROXEN

Comment Full text
  • Previous
  • 192
  • 193
  • 194
  • 195
  • 196
  • Next

Search

News categories

  • Technical Exchange News(9878)
  • Event(407)
  • SEC News(167317)
  • FDA Approval(9344)
  • Company Report(721)
  • Business News(111212)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin